PRMT5 and breast carcinoma: This is exemplified by Programmed cell death 4 (PDCD4) protein in breast cancer, which shows increased tumorigenicity when over‐expressed with PRMT5 in an orthotopic model of breast cancer (Powers et al., 2011).